I just read this e-book, simply because, according to my friend this book is written by some of the ingenious individuals who foresaw and also profited even from the financial collapse. - Sunita
I heard people are using this e-book as a Self-help guide to investing. I recently finished studying it, and never have experimented with any of the strategies; however they all appear to make sense. - Rajiv
A fantastic guide overall. Quite different from almost all other value investing publications because it concentrates on finding unique scenarios that are best to invest in. - Alexis
This particular e-book really opened up my eyes to some fresh opportunities and possibilities that while investing I should be looking for. Once you have read this traditional value investing book you will learn a lot. - Kavita
I really like the writer of this book. It is simple, properly explained, amusing, relevant, and incredibly well planned. This particular e-book is really a holy bible for dealing with unique circumstances in the market. - Saurabh

History of GlaxoSmithKline Consumer Healthcare Ltd.

1948

- Beecham [Indias] Pvt. Ltd., was incorporated at Mumbai on 8th December, under the name Group Laboratories [Indias] Pvt. Ltd., as a wholly owned subsidiary of Harold F. Ritchie [Indias] Ltd., which in turn was a wholly owned subsidiary of Beecham Group, Ltd., U.K. The Company manufacture dairy & milk products, toiletries & drugs and pharmaceuticals. The dairy products, are marketed under the name 'Horlicks', 'Elaichi Horlicks', 'Horlicks Tablets', Boost & Gopika ghee.

1949

- Since August, Beecham India Pvt. Ltd., had been manufacturing products such as 'Brylcreem' Haircream, 'Eno' fruit salt, Pure Silvikrin, Silvikrin hair dressing, Macleans tooth paste & Macleans brand indigestion powder under technical & marketing know-how from Beecham Group, limited U.K.

1958

- The Smithkline Beecham Consumer Healthcare limited was Incorporated on 30th October, as a private limited Comp. under the name Hindustan Milkfood Manufacturers, Pvt. limited It became a public limited company on 28th March 1961. It was promoted by Horlicks, Ltd., U.K., mainly to manufacture & sell malted milk food under the brand name 'Horlicks' which had hitherto been imported.

- The Comp. was incorporated in 1958 with a paid-up capital of Rs. 12 lakhs.

1960

- The name of Group Laboratories [Indias] Pvt. Ltd., was changed to Beecham [Indias] Pvt. limited with effect from 2nd January.

1963

- The capital was increased by Rs 2 lakhs, comprising of 20,000 shares of Rs 10 each, through private placements to Indian residents/financial institutions out of which 2,500 shares of Rs 10 each were issued as rights at par & 5,000 shares of Rs 10 each were issued at a premium of Rs 25 per share. The details of mode of issue of remaining 12,500 shares is not known.

1967

- On 15th March, 2,10,000 bonus shares were issued in the proportion 3:2.

1968

- On 6th March, 3,00,000 bonus shares were issued in the proportion 6:7. On 30th March, 96,174 shares were issued at a premium of Rs 7.50 each through private placement to Indian residents/financial institutions.

1969

- The worldwide interests of Horlicks, Ltd., U.K., were purchased by Beecham Group, Ltd., U.K. The subsequent association with Beecham Group, Ltd., U.K. provided access to additional international marketing expertise, worldwide experience & greater technological know-how and was instrumental in strengthening the development programme of the Company.

1972

- Details upto 31.3.1972 are given under 'Equity Capital History' on 24-11-1972, 6,17,557 Bonus shares issued in prop. 9:10, in the earlier years, 87,500 shares of Rs 10 each issued to Horlicks limited without payment in cash.

1977

- Beecham [Indias] Pvt. Ltd., a wholly owned subsidiary of Beecham Group, Ltd., U.K., was merged with the Comp. effective from 1st April, the approval for this having been received on 1st January 1979.

- 2,36,289 shares issued at a premium of Rs 20 per share: 59,072 shares each to LIC & UTI; 47,257 shares to GIC; 47,258 shares to Indian shareholders, 11,814 shares to employees of Comp. & 11,816 shares to directors, etc.

1978

- The Indian participation in the Comp. had been progressively increased & stood at 60% before the offer for sales of shares during November.

- During November, Horlicks, Ltd., U.K. offered for sale to resident Indian nationals 6,61,608 equity shares of Rs 10 each at a premium of Rs 7.50 each out of its holding in the Comp. in the following manner: [is] 30,000 shares to the employees of Company; [iis] 1,01,062 shares to members of Comp. not being holders of more than 10,000 shares as on 15th June, in the proportion 1:4 [fractions being rounded ups]; [iiis] 30,456 shares to be allotted at the discretion of Company's directors on a rational & equitable basis & [ivs] 5,00,000 shares to the public.

- After the offer for sale of shares to resident Indian nationals during November, the non-resident holding in the Comp. was reduced to 40%.

- 16,54,020 Bonus shares issued in prop. 1:1 on 12.6.1978, 1,29,886 shares of Rs 10 each issued to Beecham Group, limited U.K. on amalgamation of Beecham [Indias] Pvt. limited with the Comp. in the prop. 21.65 shares of Rs 10 each of Comp. to every shares of Rs 100 each held in Beecham [Indias] Pvt. Ltd.

-SBCH entered the capital market in 1978 with an offer for sale of equity. It manufactures & sells malted milk food products under the Horlicks brand name. Their product range includes Eno, Brylcream, Horlicks, Boost, Gopika ghee, etc.

1979

- The name of Comp. was changed from Hindustan Milkfood Manufacturers, Ltd., to HMM Ltd., with effect from 1st March. 1981

- 17,18,963 Bonus Equity shares issued in prop. 1:2.

1984

- 19,33,833 bonus equity shares issued in prop. 3:8.

1987

- 70,90,722 bonus equity shares issued in prop. 1:1.

1991

- Effective 16th September, the name was again changed to Smithkline Beecham Consumer Brands Ltd.

1994

- The Comp. expanded its production capacity at Nabha.

- Once again, the name of Comp. changed from Smithkline Beeacham Consumer Brands limited to Smithkline Beecham Consumer Healthcare Ltd.

1995

- The Comp. added one more line of production utilising the existing technology.

- 141,81,444 bonus equity shares issued in the ratio of 1:1.

1997

- 17,10,733 No. of equity shares allotted as fully paid bonus shares in prop. of 3:5.

- Infanrix-B, a single of this combination vaccine would protect children against four major infectious diseases - diphtheria, tetanus, acellular pertussis & hepatitis-B.

- The Government has shot down SmithKline Beecham plans of manufacturing & marketing pharmaceutical & over-the-counter [OTCs] products through its already set up wholly-owned subsidiary in the country.

- The pharma major, SmithKline Beecham [SKBs], has developed a two-in-one hepatitis vaccine, completed evaluation trials & claims that it has yielded good results in providing protective cover.

1998

- Smithkline Beecham Consumer Healthcare [SBCHs] has launched its Ribena brand in India with amla flavour as a refreshing health drink.

- SBCH will be setting up the new plant on a 140-acre greenfield plot provided by SmithKline Beecham Asian Private Limited [SBAPs], which has entered into a `synergistic commercial alliance' with the multinational consumer healthcare Comp. in India.

- Smithkline Beecham Consumer Healthcare [SBCHs] has launched its Ribena brand in India with amla flavour as a refreshing health drink.

- International Healthcare major SmithKline Beecham [SBs], is all set to launch a cluster of vaccines in India in 1998-99. These include a hepatitis - A vaccine, a two in one hepatitis A and B vaccine & another targeted at preventing chicken pox.

- SmithKline Beecham Consumer Healthcare Ltd, has set a second interim dividend for 1998 at Rs 2.60 per equity share, the Mumbai Stock Exchange announced.

-Ribena was launched in 1998 but was subsequently withdrawn last year.

1999

- SmithKline Beecham Consumer Healthcare Ltd [SBCHs], the nutritional healthcare leader is setting up a state of art spray drying malted food plant at Sonepat in Haryana.

- SmithKline has launched Junior Horlicks for young & flavour variants like elaichi & chocolate. It has also recently launched Amla-based Vitamin C drink Ribena from its parent stable.

- Beecham [Indias] Pvt Ltd, a wholly owned subsidiary of Beecham Group Ltd [UKs] was merged with the Comp. with effective from 1st April,1977.

- The name of Comp. was changed from Hindustan Milkfood Manufacturers Ltd to HMM Ltd with effect from 1st March, 1979. During 1994, once again, the name of Comp. changed to the present one, SmithKline Beecham Consumer Healthcare. After a major development the company has decided to set a new 21,000-tonne Horlicks plant which likely to be commissioned in 2002.

- SmithKline Beecham Consumer HealthCare Ltd has taken the firm step toward setting up a spray drying malted food plant at Sonepat, Haryana.

2000

- Smithkline Beecham Consumer Healthcare has launched the `Horlicks Plus'.

- The Comp. enter the analgesics segment by piggybacking on Crocin, a paracetamol-based formulation, commonly marketed as an antipyretic.

- In the oral care category, the Comp. is marketing two additional toothbrushes-- Interdental & V-cut --- under the Aquafresh brand. In Sep. 2000, the `Aquafresh Magic Box' promotion, the first-ever scratch-and-win campaign in the toothpaste category was launched bySBCH.

-In Dec 2000, the parent Comp. -- Smithkline Beecham Plc -- merged with Glaxo Wellcome Plc to form GlaxoSmithkline, which holds 40% of equity capital of SBCH.

2002

- Smithkline Beecham appoints Mr Ian McPherson as a Director.

- The SmithKline Beecham Consumer Healthcare [SKBCHs] has undergone a change of name to GlaxoSmithkline Beecham Consumer Healthcare, by additional of Glaxo tag to itself.

-The Board of Directors of Glaxo SmithKline Consumer Healthcare Ltd at its meeting held on August 29, 2002 have resolved for closure of operation of company undertaking situated at Kolkatta where packing operations of Comp. is being carried out with effect from the close of working hours on August 31, 2002.

-Nick Massey appointed as Director of GlaxoSmithkline Consumer Healthcare wef Nov 01, 02.

-GlaxoSmithKline Consumer Healthcare Ltd has informed BSE that at the meeting of Board of Directors held on October 25, 2002 has taken on record the following changes:

1. Mr Colin Handcock has ceased to be the Nominee Director of Comp. under Article 97A of Articles of Association of Company. Consequently Mr P Dwarakanath also ceases to be Alternate Directors to Mr Colin Handcock, Mr Nick Massey has been nominated by Horlicks Ltd as a Director under Article 97A of Articles of Association of Company

2. Mr Nick Massey has been appointed as the Managing Director of Comp. effective November 01, 2002 in place of Mr S J Scarff who ceases to be the Managing Director of Comp. w.e.f. November 01, 2002.

3. Mr S J Scarff has been appointed as the Non executive Chairman of Board of Directors of Comp. from that date.

4. Mr Sangita Reddy has tendered her resignation w.ef. November 01, 2002 to the Board of Directors & in her place Mr Colin Handcock has been appointed as a Director in casual vacancy w.e.f. November 01, 2002. Mr P Dwarakanath has been appointed as an Alternate Director of Mr Colin Handcock at the above mentioned Board Meeting

5. Mrs Sangita Reddy who was a member of Investor Greivance Committee has ceased to be member due to her resignation & in her place Mr P S Mukherjee, Wholetime Director of Comp. has been appointed as a member of Investor Greivance Committee w.e.f. November 01, 2002.

2003

-Mr.V.Thyagarajan & Mr.R Subbarayan ceased to be the Director & Alternate Director on the Board of Company.

-GSK is phasing out its premium toothpaste brand Aquafresh from the Indian Market.

-GSK Ltd has informed that Mr. Abhinandan Chatterjee, Director of Finance & Information Technology has desired to take early retirement from the services of the company.

-Horlicks, the flagship brand of GlaxoSmithKline which slipped from 10th position to 16th position in the brand equity survey of India has been relaunched by company.

-Mr. Gautam K Chakraborty has been appointed as a wholetime director in the casual vacancy created by resignation of Mr. A Chatterjee.

-Qualigens Fine Chemicals [QFCs], a division of GlaxoSmithKline [GSKs] India, that manufactures & markets research & laboratory chemicals & lab-ware has inked a marketing agreement with Honeywell Burdick and Jackson

2005

-GlaxoSmithkline launches variant of Horlicks at Visakhapatnam

2006

-GSK enters into five years agreement with Genpact

-GlaxoSmithkline Consumer Healthcare Ltd has appointed Mr Zubair Ahmed as the Managing Director of Company.

2007

-GlaxoSmithkline Consumer Healthcare Ltd has informed that the Comp. has appointed Karvy Computershare Pvt Ltd [KCPLs], Hyderabad as the Company Registrar and Transfer Agent [RTAs] w.e.f. September 01, 2007.